241 related articles for article (PubMed ID: 14759809)
1. CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses.
Reyes-Sandoval A; Ertl HC
Mol Ther; 2004 Feb; 9(2):249-61. PubMed ID: 14759809
[TBL] [Abstract][Full Text] [Related]
2. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
Kuzmin AI; Galenko O; Eisensmith RC
Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
[TBL] [Abstract][Full Text] [Related]
3. Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides.
Hodges BL; Taylor KM; Joseph MF; Bourgeois SA; Scheule RK
Mol Ther; 2004 Aug; 10(2):269-78. PubMed ID: 15294174
[TBL] [Abstract][Full Text] [Related]
4. The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector.
Pasquini S; Deng H; Reddy ST; Giles-Davis W; Ertl HC
Gene Ther; 1999 Aug; 6(8):1448-55. PubMed ID: 10467369
[TBL] [Abstract][Full Text] [Related]
5. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.
Mitsui M; Nishikawa M; Zang L; Ando M; Hattori K; Takahashi Y; Watanabe Y; Takakura Y
J Gene Med; 2009 May; 11(5):435-43. PubMed ID: 19291673
[TBL] [Abstract][Full Text] [Related]
6. Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation.
Chen ZY; Riu E; He CY; Xu H; Kay MA
Mol Ther; 2008 Mar; 16(3):548-56. PubMed ID: 18253155
[TBL] [Abstract][Full Text] [Related]
7. Persistence of plasmid-mediated expression of transgenes in human mesenchymal stem cells depends primarily on CpG levels of both vector and transgene.
Bruter AV; Kandarakov OF; Belyavsky AV
J Gene Med; 2018 Feb; 20(2-3):e3009. PubMed ID: 29424052
[TBL] [Abstract][Full Text] [Related]
8. Construction and characterization of E1- and E3-deleted adenovirus vectors expressing two antigens from two separate expression cassettes.
Small JC; Kurupati RK; Zhou X; Bian A; Chi E; Li Y; Xiang Z; Ertl HC
Hum Gene Ther; 2014 Apr; 25(4):328-38. PubMed ID: 24367921
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo.
Tan Y; Li S; Pitt BR; Huang L
Hum Gene Ther; 1999 Sep; 10(13):2153-61. PubMed ID: 10498247
[TBL] [Abstract][Full Text] [Related]
10. In vitro assay of immunostimulatory activities of plasmid vectors.
Jiang W; Reich CF; Pisetsky DS
Methods Mol Med; 2006; 127():55-70. PubMed ID: 16988446
[TBL] [Abstract][Full Text] [Related]
11. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
[TBL] [Abstract][Full Text] [Related]
12. Biology of E1-deleted adenovirus vectors in nonhuman primate muscle.
Zoltick PW; Chirmule N; Schnell MA; Gao GP; Hughes JV; Wilson JM
J Virol; 2001 Jun; 75(11):5222-9. PubMed ID: 11333904
[TBL] [Abstract][Full Text] [Related]
13. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
[TBL] [Abstract][Full Text] [Related]
14. [Optimization of in-vivo gene transfer through regulating biological response to vectors].
Nishikawa M
Yakugaku Zasshi; 2006 Nov; 126(11):1029-37. PubMed ID: 17077609
[TBL] [Abstract][Full Text] [Related]
15. Methylated CpG-containing plasmid activates the immune system.
Cornélie S; Poulain-Godefroy O; Lund C; Vendeville C; Ban E; Capron M; Riveau G
Scand J Immunol; 2004 Feb; 59(2):143-51. PubMed ID: 14871290
[TBL] [Abstract][Full Text] [Related]
16. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific tolerance of human alpha1-antitrypsin induced by helper-dependent adenovirus.
Cerullo V; McCormack W; Seiler M; Mane V; Cela R; Clarke C; Rodgers JR; Lee B
Hum Gene Ther; 2007 Dec; 18(12):1215-24. PubMed ID: 18021020
[TBL] [Abstract][Full Text] [Related]
18. Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice.
Dicks MD; Spencer AJ; Coughlan L; Bauza K; Gilbert SC; Hill AV; Cottingham MG
Sci Rep; 2015 Nov; 5():16756. PubMed ID: 26576856
[TBL] [Abstract][Full Text] [Related]
19. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.
Wang Q; Greenburg G; Bunch D; Farson D; Finer MH
Gene Ther; 1997 May; 4(5):393-400. PubMed ID: 9274715
[TBL] [Abstract][Full Text] [Related]
20. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Ji L; Bouvet M; Price RE; Roth JA; Fang B
Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
